Sleep Apnea Implants Market Analysis And Forecast To 2032: By Product (Hypoglossal Neurostimulation Devices, Palatal Implants, Bone Screw System, Phrenic Nerve Stimulator), By Indication (Central Sleep Apnea, Obstructive Sleep Apnea), By End-use (Hospital

Sleep Apnea Implants Market Analysis And Forecast To 2032: By Product (Hypoglossal Neurostimulation Devices, Palatal Implants, Bone Screw System, Phrenic Nerve Stimulator), By Indication (Central Sleep Apnea, Obstructive Sleep Apnea), By End-use (Hospital, Ambulatory Surgical Centers), And Region

The global sleep apnea implants market was valued at USD 310.3 Million in 2021 and it is anticipated to grow up to USD 1516.5 Million by 2031, at a CAGR of 17.2% during the forecast period.

Sleep apnea implants refers to discreet devices implanted in the patient’s body to stimulate the natural breathing mechanism, open the airway, and enable the oxygen flow. Sleep apnea implants aid in reducing the impact of sleep apnea & the devices are majorly used in managing moderate to severe sleep apnea.
Global Sleep Apnea Implants Market Scope and Report Structure
Market Trends and Drivers
The significant increase in the number of individuals suffering from sleep sleep apnea is one of the key factors driving the market for sleep apnea implants. Obstructive sleep apnea (OSA) is a chronic condition that causes frequent breathing disruptions during sleep and is significantly underdiagnosed. This illness occurs when the muscles of the throat and tongue, as well as soft tissues, relax and collapse, reducing the amount of air that reaches the lungs. OSA promotes serious health effects and co-morbidities, such as cardiovascular disease, atherosclerosis, heart failure, hypertension, stroke, diabetes, and depression, among others, resulting in substantial mortality.

According to the Lancet Respiratory Medicine publication, which was published in 2019, OSA is the most serious sleep disease, impacting around 936 million individuals worldwide. Around 425 million people have moderate-to-severe OSA and require therapy. Similarly, as of 2019, over 14.3 million people in Germany suffer with this illness. As a result of the growing patient population, the market for sleep apnea implants is expected to increase significantly due to rising adoption and awareness. As a result of these implants providing an efficient solution to patients for managing obstructive sleep apnea, the market is expected to experience exceptional growth in the near future.
Market Restraints and Challenges
The high costs of sleep apnea implants, severe government regulations, and peri-operative issues may all have an adversely impact on business growth. The high cost of sleep apnea implants, notably hypoglossal neurostimulation devices and phrenic nerve stimulators, may affect device acceptance and thus market growth. For instance, as of 2019, the Inspire Medical System’s hypoglossal nerve stimulation implant was priced at USD 23,800 in the U.S. & USD 23,400 in Europe. Such incremental costs would affect the adoption of these sleep apnea implants. Furthermore, the U.S. FDA overviews the R&D activities, approval, and post-approval surveillance associated with medical devices, including sleep apnea implants. Certain sleep apnea implants, including the Inspire UAS system is classified as class III medical device. These devices are required to adhere to stringent regulatory approval processes & compliances including the premarket approval (PMA). Thus, the strict regulatory framework & high cost may limit the adoption of sleep apnea implants, further hindering the industry growth.
Global Sleep Apnea Implants Market Segmental Overview

The report analyses the global sleep apnea implants market based on product, indication, end-user, and region.

Global Sleep Apnea Implants Market by Product


Based on product, the market is segregated as hypoglossal neurostimulation devices, palatal implants, bone screw system, and phrenic nerve stimulators. The hypoglossal neurostimulation devices accounted for majority market share in 2021 and is expected to register highest CAGR during the estimation timeframe. This majority market share is pertaining to rapid adoption of hypoglossal neurostimulation devices and higher efficacy in managing obstructive sleep apnea. Hypoglossal nerve stimulation emerged as an effective technique for muscle stimulation. The hypoglossal nerve controls the movement of the tongue and airway muscles. Hypoglossal neurostimulation helps to keep the airway open during sleep by stimulating this nerve. Over the last decade, novel technologies focusing on hypoglossal nerve stimulation have emerged as a treatment option for persons suffering from moderate-to-severe OSA who are non-compliant with traditional CPAP therapy. Furthermore, continuous clinical studies and R&D activities to analyse and promote efficacy are expected to expand the sleep apnea implants market share.

Global Sleep Apnea Implants Market by Indication


Based on the indication, the sleep apnea implants market is divided into the central sleep apnea, and obstructive sleep apnea. Among these obstructive sleep apnea segment was valued significant market size in 2021 and is anticipated to grow at highest CAGR from 2022-2030. This dominant market growth is majorly attributed to the increasing prevalence of obstructive sleep apnea is a primary contributor to this dominant market expansion. Obstructive sleep apnea is a disorder characterized by recurring upper airway blockage during sleep, according to a 2019 article published by the National Centers for Biotechnology Information. This problem affects 6% to 7% of the population and is associated with increased recurrence of cardiovascular disease, stroke, daily drowsiness, and worse quality of life. These symptoms are most common in people with moderate-to-severe OSA, often known as an apnea hypopnea index (AHI) more than 15 episodes per hour. As a result, the significant prevalence of OSA is likely to accelerate the segmental growth.

Global Sleep Apnea Implants Market by End-user


With regards to end-user, the sleep apnea implants market is divided into hospitals, ambulatory surgical centers, and others. The ambulatory surgical centres segment accounted for significant market share in 2021 and is predicted to grow at a substantial CAGR throughout the forecast period. The increased acceptance of these implants and implantation methods in these healthcare settings has resulted in this overwhelming market share. Ambulatory surgical centres offer revolutionary surgical technologies and advanced implants, and these treatments are provided by certified surgeons and healthcare personnel, ensuring overall market expansion and driving desire for these facilities. Furthermore, the availability and rising demand for surgical treatments in various healthcare settings for improved patient management and care propels the growth of the sleep apnea implants market in the coming years.
Geographical Analysis of Global Sleep Apnea Implants Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America sleep apnea implants market revenue is poised to grow significant CAGR during the forthcoming years. This can be attributed to the various causes, including increased OSA prevalence and incidence, a high OSA-related disease burden, product releases, and the presence of large companies across the country. According to the Lancet Respiratory journal statistics, roughly 23.6 million persons in the United States suffered from OSA in 2019. The large OSA population base has resulted in an incremental increase in the OSA-related economic burden. Furthermore, the low awareness of OSA and underdiagnosed patients provide a significant market development opportunity for the leading companies. According to Nyxoah's 2021 annual report, OSA is significantly underdiagnosed, with the diagnosis rate in the United States averaging 18%. In addition, the presence
Major Players in the Global Sleep Apnea Implants Market
The key players in the sleep apnea implants market are Inspire Medical Systems, Inc., Medtronic plc., Nyxoah SA, Siesta Medical, Respicardia, Inc. (Asahi Kasei Company), LivaNova, DeVilbiss Healthcare LLC, Somnowell, Koninklijke Philips N.V, and LinguaFlex LLC, among others.
COVID-19 Impact
The COVID-19 pandemic emerged as an unprecedented disease outbreak, affecting the industrial sectors by disrupting the supply chain. During the initial period of the pandemic, in the first half of 2020, the pandemic hampered the growth of the sleep apnea implants market. National emergencies and lockdowns were imposed in numerous economies to halt the spread of the SARS-CoV-2 virus. The shutdown and travel restrictions had an influence on medical practises. The coronavirus pandemic has an impact on the medical device business by restricting product uptake and associated procedures. It had an impact on market players' business operations by significantly reducing and delaying the number of implantation procedures conducted and patients assessed for eligibility for sleep apnea implants therapy.

Furthermore, as a result of the pandemic, industry participants had some difficulties in recruiting individuals for clinical studies. The collaborative efforts of certain regulatory authorities and market players, on the other hand, contributed in reducing the impact of the pandemic. According to Inspire Medical Systems, all Inspire therapy procedures scheduled for March 2020 have been cancelled or postponed. Although, by October 2020, the majority of surgical facilities have completed these implantation operations. Elective surgical treatments will also reach pre-pandemic levels in 2021. Thus, the COVID-19 pandemic delayed industry growth marginally; however, restoring surgical volume would help market expansion in the near future.
Recent Developments

In February 2022, LivaNova PLC announced the first patient implanted in the investigational device exemption (IDE) clinical study, Treating Obstructive Sleep Apnea using Targeted Hypoglossal Neurostimulation (OSPREY).
In June 2021, LivaNova PLC announced it has received approval from the U.S. Food and Drug Administration (FDA) to proceed with its investigational device exemption (IDE) clinical study, Treating Obstructive Sleep Apnea using Targeted Hypoglossal Neurostimulation (OSPREY)
In April 2021, Siesta Medical announced the publication a clinical study highlighting the clinical efficacy and effectivity of AIRLIFT procedure for the treatment of obstructive sleep apnea. This development helped the company to highlight its product capabilities and thereby gain competitive advantage over its competitors.
In March 2021, Inspire Medical Systems, Inc., announced receipt of U.S. Food and Drug Administration approval for an improved surgical implant procedure that eliminates one incision with a revised placement of the pressure sensing lead. This newly approved procedure will reduce the average procedure time for Inspire therapy by approximately 20 percent.
In May 2019, Siesta Medical announced the U.S. FDA clearance for its Encore System for extended indications. The Encore System is employed in AIRLIFT hyoid suspension that is used to treat airway obstructions and obstructive sleep apnea severity. This development helped the company to drive its revenue generation.

Frequently Asked Questions
Q1. How big is the medical power supply market?

Ans. The global sleep apnea implants market size was USD 310.3 Million in 2021 and is anticipated to reach USD 1,516.49 Million in 2031, growing at a rate of 17.2% from 2022 to 2031.

Q2. What is the sleep apnea implants market growth rate?

Ans. The growth rate of the sleep apnea implants market is 17.2%.

Q3. Which region holds a major market share for the market?

Ans. North America holds a major market share of the sleep apnea implants market in 2021.

Q4. Which segment accounted for the largest sleep apnea implants market share?

Ans. By end user, the ASC segment accounted for the largest sleep apnea implants market share.

Q5. Who are the key players in the sleep apnea implants market?

Ans. The global sleep apnea implants market report includes players such as Inspire Medical Systems, Inc., Medtronic plc., Nyxoah SA, Siesta Medical, Respicardia, Inc. (Asahi Kasei Company), LivaNova, DeVilbiss Healthcare LLC, Somnowell, Koninklijke Philips N.V, and LinguaFlex LLC, among others.

Q6. What are the factors driving the sleep apnea implants market growth?

Ans. The major factors driving the growth of the market are Increasing prevalence of obstructive sleep apnea.

Q7. What are the key growth strategies of sleep apnea implants market players?

Ans. The key growth strategies of sleep apnea implants market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the sleep apnea implants market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the sleep apnea implants market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.